1.
ClinicalTrials.gov; 25/04/2022; TrialID: NCT05346042
Clinical Trial Register
| ICTRP | ID: ictrp-NCT05346042
ABSTRACT
Condition:
COVID-19Intervention:
Other: duration infectiousnessPrimary outcome:
the probability and the duration of being infectious in hospitalized COVID-19 patients, consequently influencing the decision on cessation of isolationCriteria:
Inclusion Criteria:
In order to be eligible to participate in this study, a subject must meet all of the
following criteria:
- Admission for COVID-19 and tested positive between the end of February 2020 and
December 1st 2021.
- Admission for other reasons than COVID-19, but during hospital stay detected with
COVID-19.
- Patients =18 years old.
Exclusion Criteria:
A potential subject who meets any of the following criteria will be excluded:
- Adult patients with registered opt-out for using clinical and/or laboratory data.
- Patients <18 years old.
2.
medrxiv; 2022.
Preprint
in English
| medRxiv | ID: ppzbmed-10.1101.2022.04.12.22273760
ABSTRACT
SARS-CoV-2 Omicron variants BA.1 and BA.2 seem to show reduced clinical severity. We classified 172 COVID-19 Omicron patient admissions. 66.2% of patients were admitted with primary or admission-contributing COVID-19. We therefore must be careful to base healthcare and public health decisions on the total number of hospitalized COVID-19 patients alone.